Gritstone bio, Inc. Quarterly Operating Income (Loss) in USD from Q1 2017 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Gritstone bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2017 to Q2 2024.
Gritstone bio, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$27.6M, a 22.8% increase year-over-year.
Gritstone bio, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$136M, a 3.12% decline year-over-year.
Gritstone bio, Inc. annual Operating Income (Loss) for 2023 was -$140M, a 15.9% decline from 2022.
Gritstone bio, Inc. annual Operating Income (Loss) for 2022 was -$120M, a 60.1% decline from 2021.
Gritstone bio, Inc. annual Operating Income (Loss) for 2021 was -$75.2M, a 29.1% increase from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$136M	-$27.6M	+$8.14M	+22.8%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	-$145M	-$39.8M	-$4.99M	-14.3%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$140M	-$30.5M	+$1.45M	+4.53%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-05
Q3 2023	-$141M	-$38.6M	-$8.73M	-29.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	-$132M	-$35.7M	-$6.06M	-20.4%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-13
Q1 2023	-$126M	-$34.8M	-$5.85M	-20.2%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	-$120M	-$31.9M	-$2.14M	-7.17%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-05
Q3 2022	-$118M	-$29.9M	-$1.72M	-6.12%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	-$117M	-$29.7M	-$4.5M	-17.9%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	-$112M	-$29M	-$36.9M	-467%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	-$75.2M	-$29.8M	-$2.64M	-9.71%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-05
Q3 2021	-$72.6M	-$28.2M	-$2.01M	-7.7%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	-$70.6M	-$25.2M	+$891K	+3.42%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	-$71.5M	$7.9M	+$34.6M		Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	-$106M	-$27.1M	+$1.17M	+4.12%	Oct 1, 2020	Dec 31, 2020	10-K	2021-03-11
Q3 2020	-$107M	-$26.1M	+$2.34M	+8.22%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-03
Q2 2020	-$110M	-$26.1M	-$3.84M	-17.3%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	-$106M	-$26.7M	-$7.74M	-40.9%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	-$97.9M	-$28.3M	-$10.3M	-57.1%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-11
Q3 2019	-$87.7M	-$28.5M	-$9.87M	-53%	Jul 1, 2019	Sep 30, 2019	10-K	2021-03-11
Q2 2019	-$77.8M	-$22.2M	-$6.71M	-43.3%	Apr 1, 2019	Jun 30, 2019	10-K	2021-03-11
Q1 2019	-$71.1M	-$18.9M	-$5.49M	-40.9%	Jan 1, 2019	Mar 31, 2019	10-K	2021-03-11
Q4 2018	-$65.6M	-$18M	-$447K	-2.54%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-11
Q3 2018	-$65.1M	-$18.6M	-$9.13M	-96.2%	Jul 1, 2018	Sep 30, 2018	10-K	2020-03-11
Q2 2018	-$56M	-$15.5M	-$7.65M	-97.5%	Apr 1, 2018	Jun 30, 2018	10-K	2020-03-11
Q1 2018	-$48.4M	-$13.4M	-$6.6M	-96.4%	Jan 1, 2018	Mar 31, 2018	10-K	2020-03-11
Q4 2017	-$41.8M	-$17.6M			Oct 1, 2017	Dec 31, 2017	10-K	2019-03-28
Q3 2017		-$9.49M			Jul 1, 2017	Sep 30, 2017	10-K	2019-03-28
Q2 2017		-$7.85M			Apr 1, 2017	Jun 30, 2017	10-K	2019-03-28
Q1 2017		-$6.84M			Jan 1, 2017	Mar 31, 2017	10-K	2019-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.